Health Trials

Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive

1

Review clinical trials related to Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 2 Study of ABSK043 Combined With Osimertinib

This is a phase 2, open-Label study to evaluate the efficacy and safety of ABSK043 Combined with Osimertinib in participants with EGFR-Mutated locally advanced or metastatic Non-Small Cell Lung Cancer

Participants needed: 72
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Abbisko Therapeutics Co, LtdUpdated: Jul 17, 2026Locations: 7
Eligibility criteria

Aged 18 or above, male or female. [+13]

1. Histological or cytological examinations suggest that NSCLC squamous cells is...

Read more